For the diagnosis of bronchial carcinoma the fibreoptic bronchoscope has a wider visual range' than the rigid bronchoscope, and gives a higher rate of positive biopsy specimens when tumour is visible2 and a greater accuracy of cell type prediction.3 But histological interpretation of individual bronchial biopsy specimens obtained through the fibreoptic bronchoscope may be difficult because they are smaller than those obtained through the rigid bronchoscope, and because they may be crushed during withdrawal through the biopsy channel of the instrument. Rudd et al3 suggested that the greater accuracy of prediction of carcinoma cell type by fibreoptic bronchial biopsies might be attributable to the fact that a larger number of biopsy samples is usually taken during fibreoptic bronchoscopy than during rigid bronchoscopy.
ABSTRACT The findings in bronchial biopsy specimens obtained at fibreoptic bronchoscopy in 271 patients with bronchial carcinoma were reviewed. Fifty-nine per cent of 703 specimens taken from the site of bronchoscopically visible tumours in 215 patients provided evidence of carcinoma. Unequivocal histological evidence of carcinoma was obtained in 78-6% of the 215 patients with visible tumours. When only one biopsy specimen was taken evidence of carcinoma was obtained in 65.2% of cases. At least five biopsy specimens were required to provide a greater than 90% probability of obtaining at least one positive sample. The anatomical site of the tumour had no significant effect on the proportion of biopsy specimens that were positive or the frequency of obtaining at least one positive sample. When extrinsic bronchial compression was the only visible abnormality evidence of carcinoma was obtained by bronchial biopsy in 26.8% of 56 cases.
For the diagnosis of bronchial carcinoma the fibreoptic bronchoscope has a wider visual range' than the rigid bronchoscope, and gives a higher rate of positive biopsy specimens when tumour is visible2 and a greater accuracy of cell type prediction.3 But histological interpretation of individual bronchial biopsy specimens obtained through the fibreoptic bronchoscope may be difficult because they are smaller than those obtained through the rigid bronchoscope, and because they may be crushed during withdrawal through the biopsy channel of the instrument. Rudd et al3 suggested that the greater accuracy of prediction of carcinoma cell type by fibreoptic bronchial biopsies might be attributable to the fact that a larger number of biopsy samples is usually taken during fibreoptic bronchoscopy than during rigid bronchoscopy.
It is generally recommended that multiple biopsy specimens should be taken during fibreoptic bronchoscopy but the optimal number for the diagnosis of carcinoma has not been defined. This study examines the relation between the number of biopsy samples taken during fibreoptic bronchoscopy and the frequency of obtaining histological evidence of carcinoma when an endobronchial lesion is seen and when the only visible abnormality is extrinsic bronchial compression.
Reprints will not be available from the authors. Table 2 shows the relation between the number of biopsy specimens taken from visible tumour and the Overall the proportion of biopsy samples showing carcinoma was about the same regardless of the number taken. Each successive specimen might therefore be assumed to have an independent and equal chance of showing carcinoma. From this assumption the probability of obtaining at least one positive biopsy specimen can be calculated according to the number of specimens taken. The probability, Pn, of obtaining at least one positive specimen when n specimens are taken is given by P,n = 1 -(1 -p r, where p is the probability that a single specimen will be positive. Table 2 shows these estimated probabilities, on the assumption that the chance of a single sample being positive is 59-2%, which was the observed proportion of total biopsy samples that were positive. These probabilities are compared with the observed frequency of obtaining at least one positive specimen. When only one biopsy specimen was taken the frequency of obtaining a positive was slightly higher than expected. With multiple specimens the observed frequency was less than the estimated probability of obtaining at least one positive specimen until six were taken. Table 3 shows the proportions of biopsy specimens that were positive for each cell type. There was a trend towards a higher proportion of positive sam-Gellert, Rudd, Sinha, Geddes 
Methods

EFFECTS OF CELL TYPE AND SITE OF LESION ON DIAGNOSTIC YIELD
Discussion
The usual practice is to take multiple biopsy specimens from endobronchial lesions seen at fibreoptic bronchoscopy to provide adequate tissue for histological examination. Recent reviews of bronchoscopic techniques have suggested that at least three specimens should be taken,56 but the optimal number has not been established. The aim should be to avoid the unnecessary risk of haemorrhage and the waste of laboratory resources resulting from taking more samples than are required to maximise the diagnostic yield. We found that 59% of biopsy specimens showed evidence of carcinoma. If the probability of each successive specimen being positive was 59% the diagnostic yield would exceed 90% with three, but in practice the yield from three specimens was only 75% and five were required to achieve a yield exceeding 90%.
Unequivocal evidence of carcinoma was obtained by bronchial biopsy in 78-6% of cases with tumour visible at fibreoptic bronchoscopy. This yield is similar to that of 71% reported by Kvale et al, 7 but somewhat lower than those of 89% reported by Knight and Clarke8 and 91% by Macdonald9 and by Webb and Clarke.2 Knight and Clarke, 8 however, included biopsy samples reported as "suggestive of carcinoma" as positive, while Macdonald9 and Webb and Clarke2 did not state whether equivocal reports were considered positive. Knight and Clarke8 found that positive biopsy rates for visible tumours improved over a period after the introduction of fibreoptic bronchoscopy at their institution. We have found that bronchoscopists with greater experience obtain a histological diagnosis in a higher proportion of cases with visible tumour.'0 This factor may partly explain differences in positive biopsy rates reported in different studies.
Brush biopsy samples and bronchial aspirates may occasionally provide evidence of carcinoma when bronchial biopsy is negative.9 11 12 Their interpretation requires expert cytopathological opinion, which is not available in many institutions. Even when such facilities are available the accuracy of prediction of cell type is lower by cytological than by histological techniques.3 13 Distortion of bronchial anatomy by extrinsic compression without any visible abnormality of the bronchial mucosa is a common bronchoscopic finding in bronchial carcinoma. It is common practice to take mucosal biopsy specimens from the site of compression but there is little information about the diagnostic yield in such circumstances. We found that histological evidence of carcinoma was obtained in 26*8% of such cases. The proportion of biopsy specimens that were positive was lower than when an endobronchial lesion was found, but fewer specimens per case were taken when.only extrinsic compression was seen and this may have contributed to the lower frequency of obtaining at least one positive sample.
When tumour was visible there was a trend towards a higher proportion of positive biopsy samples in oat-cell carcinoma than in other cell types, although this did not reach statistical significance. This was also true for cases where only extrinsic compression was seen.
We conclude that at least five bronchial biopsy specimens should be taken to maximise the chance of obtaining histological evidence of carcinoma when an endobronchial tumour or extrinsic bronchial compression is seen at fibreoptic bronchoscopy. 
